(2024). Comparative Study between Chromitron Versus Metformin as an Adjuvant Agent for Ovulation Induction with Letrozole in Patients with Polycystic Ovary Syndrome. test, 95(1), 2283-2288. doi: 10.21608/ejhm.2024.361998
. "Comparative Study between Chromitron Versus Metformin as an Adjuvant Agent for Ovulation Induction with Letrozole in Patients with Polycystic Ovary Syndrome". test, 95, 1, 2024, 2283-2288. doi: 10.21608/ejhm.2024.361998
(2024). 'Comparative Study between Chromitron Versus Metformin as an Adjuvant Agent for Ovulation Induction with Letrozole in Patients with Polycystic Ovary Syndrome', test, 95(1), pp. 2283-2288. doi: 10.21608/ejhm.2024.361998
Comparative Study between Chromitron Versus Metformin as an Adjuvant Agent for Ovulation Induction with Letrozole in Patients with Polycystic Ovary Syndrome. test, 2024; 95(1): 2283-2288. doi: 10.21608/ejhm.2024.361998